| 04/01/2026 4:00 PM | Aminov Erez (1986112) Reporting MIRA Pharmaceuticals (1904286) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 1:02 PM | MIRA Pharmaceuticals (1904286) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/23/2026 8:00 AM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/03/2026 3:01 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 7:30 PM | Aminov Erez (1986112) Reporting MIRA Pharmaceuticals (1904286) Issuer | Form 5 Annual statement of changes in beneficial ownership of securities | |
| 12/05/2025 4:15 PM | MIRA Pharmaceuticals (1904286) Filer | Form 424B5 | |
| 12/05/2025 4:15 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/13/2025 6:31 AM | MIRA Pharmaceuticals (1904286) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/16/2025 3:01 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/15/2025 3:01 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/03/2025 7:00 PM | MIRA Pharmaceuticals (1904286) Reporting Telomir Pharmaceuticals, Inc. (1971532) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for MIRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/03/2025 7:00 PM | Aminov Erez (1986112) Reporting MIRA Pharmaceuticals (1904286) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/03/2025 7:00 PM | MIRA Pharmaceuticals (1904286) Issuer Shekhat Denil Nanji (2016605) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/30/2025 6:00 AM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/22/2025 6:30 AM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/18/2025 7:00 PM | Aminov Erez (1986112) Reporting MIRA Pharmaceuticals (1904286) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2025 3:02 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 4:25 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/03/2025 3:05 PM | Aminov Erez (1986112) Reporting MIRA Pharmaceuticals (1904286) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2025 7:00 AM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2025 7:00 AM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/08/2025 4:15 PM | MIRA Pharmaceuticals (1904286) Filer | Form DEFA14A | |
| 08/08/2025 4:15 PM | MIRA Pharmaceuticals (1904286) Filer | Form DEFM14A | |
| 07/29/2025 4:26 PM | MIRA Pharmaceuticals (1904286) Filer | Form PRER14A | |
| 07/28/2025 3:01 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/10/2025 3:19 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/08/2025 4:25 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/30/2025 6:30 AM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/24/2025 3:01 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/17/2025 7:01 AM | MIRA Pharmaceuticals (1904286) Filer | Form PREM14A | |
| 06/10/2025 6:12 AM | MIRA Pharmaceuticals (1904286) Issuer Weichselbaum Alan (1435390) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/28/2025 7:00 AM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/21/2025 4:25 PM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/08/2025 6:30 AM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2025 6:30 AM | MIRA Pharmaceuticals (1904286) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |